Skip to main content
. 2022 Mar 12;14(3):629. doi: 10.3390/pharmaceutics14030629
AD Alzheimer’s disease
ASD autism spectrum disorder
AUC area under curve
BBB blood-brain barrier
CNS central nervous system
CSF cerebro-spinal fluid
IV intravenous
LENK leucine-5-enkaphalin
MMP matrix metalloproteinase
NGF nerve growth factor
NLC nanostructured lipid carrier
OEF olfactory ensheathing fibroblast
OSN olfactory sensory neuron
PD Parkinson’s disease
PEG polyethylene glycol
PGLA poly(l-lactide-co-glycolide)
RMS rostral migratory stream
TJ tight junction